Repligen to Buy BioLife Solutions for $1.5 Billion, Expanding Cell Therapy ReachMarketBeat • 07/22/26
Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation MediaGlobeNewsWire • 07/22/26
Repligen (RGEN) Down 3.2% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 06/04/26
Repligen Corporation (RGEN) Presents at 46th Annual William Blair Growth Stock Conference TranscriptSeeking Alpha • 06/03/26
Repligen Corporation to Present at William Blair 46th Annual Growth Stock ConferenceGlobeNewsWire • 05/22/26
Repligen Announces Publication of the Company's 2025 Corporate Sustainability ReportGlobeNewsWire • 05/20/26
Repligen Corporation (RGEN) Presents at Bank of America Global Healthcare Conference 2026 TranscriptSeeking Alpha • 05/12/26
Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare ConferenceGlobeNewsWire • 05/07/26
Repligen Reports First Quarter 2026 Financial Results and Updates Full Year 2026 Financial GuidanceGlobeNewsWire • 05/05/26
Analysts Estimate Repligen (RGEN) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 04/28/26
Conestoga Capital Small Cap Portfolio Quarterly Scorecard: Buys, Sells, And StandoutsSeeking Alpha • 04/23/26